{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T01:22:45Z","timestamp":1773796965701,"version":"3.50.1"},"reference-count":55,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22202MFDS173"],"award-info":[{"award-number":["22202MFDS173"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HV22C0079"],"award-info":[{"award-number":["HV22C0079"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HN23C009000"],"award-info":[{"award-number":["HN23C009000"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["HV23C0090"],"award-info":[{"award-number":["HV23C0090"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.vaccine.2024.02.039","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T15:55:39Z","timestamp":1708098939000},"page":"1941-1952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Immunogenicity and protective efficacy of RipA, a peptidoglycan hydrolase, against Mycobacterium tuberculosis Beijing outbreak strains"],"prefix":"10.1016","volume":"42","author":[{"given":"Kee Woong","family":"Kwon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Han-Gyu","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunsol","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hagyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa-Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Jae","family":"Shin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.02.039_b0005","doi-asserted-by":"crossref","first-page":"e20","DOI":"10.1016\/S2666-5247(22)00359-7","article-title":"WHO's global tuberculosis report 2022","volume":"4","author":"Bagcchi","year":"2023","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.vaccine.2024.02.039_b0010","doi-asserted-by":"crossref","unstructured":"World Health O. BCG vaccine: WHO position paper, February 2018 - Recommendations. Vaccine. 2018;36:3408-10.","DOI":"10.1016\/j.vaccine.2018.03.009"},{"key":"10.1016\/j.vaccine.2024.02.039_b0015","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0140-6736(95)92348-9","article-title":"Variation in protection by BCG: implications of and for heterologous immunity","volume":"346","author":"Fine","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.02.039_b0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/cid\/cit790","article-title":"Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials","volume":"58","author":"Mangtani","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.02.039_b0025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2024.02.039_b0030","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fimmu.2018.00121","article-title":"Next-generation vaccines based on Bacille Calmette-Gu\u00e9rin","volume":"9","author":"Nieuwenhuizen","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0035","doi-asserted-by":"crossref","DOI":"10.3390\/cells9122673","article-title":"Recent advances in the development of protein- and peptide-based subunit vaccines against tuberculosis","volume":"9","author":"Bellini","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.vaccine.2024.02.039_b0040","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa1909953","article-title":"Final analysis of a trial of M72\/AS01(E) vaccine to prevent tuberculosis","volume":"381","author":"Tait","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.02.039_b0045","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S2213-2600(20)30319-2","article-title":"Safety and immunogenicity of the adjunct therapeutic vaccine ID93 + GLA-SE in adults who have completed treatment for tuberculosis: a randomised, double-blind, placebo-controlled, phase 2a trial","volume":"9","author":"Day","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.vaccine.2024.02.039_b0050","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1164\/rccm.201802-0366OC","article-title":"Dose optimization of H56:IC31 vaccine for tuberculosis-endemic populations. A double-blind, placebo-controlled, dose-selection trial","volume":"199","author":"Suliman","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2024.02.039_b0055","doi-asserted-by":"crossref","first-page":"44151","DOI":"10.1038\/srep44151","article-title":"Novel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hyper-virulent Mycobacterium tuberculosis strain K","volume":"7","author":"Kwon","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.02.039_b0060","doi-asserted-by":"crossref","first-page":"10467","DOI":"10.1007\/s00253-015-6952-z","article-title":"APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice","volume":"99","author":"Soleimanpour","year":"2015","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0065","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1189\/jlb.0912435","article-title":"Mycobacterium tuberculosis RpfB drives Th1-type T cell immunity via a TLR4-dependent activation of dendritic cells","volume":"94","author":"Kim","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.micinf.2011.08.011","article-title":"Potential of Mycobacterium tuberculosis resuscitation-promoting factors as antigens in novel tuberculosis sub-unit vaccines","volume":"14","author":"Romano","year":"2012","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2024.02.039_b0075","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/31159","article-title":"Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence","volume":"393","author":"Cole","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2024.02.039_b0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00873692","article-title":"Secretion of an antibacterial factor during resuscitation of dormant cells in Micrococcus luteus cultures held in an extended stationary phase","volume":"67","author":"Mukamolova","year":"1995","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.vaccine.2024.02.039_b0085","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1023\/A:1000881918216","article-title":"On resuscitation from the dormant state of Micrococcus luteus","volume":"73","author":"Mukamolova","year":"1998","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.vaccine.2024.02.039_b0090","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1111\/febs.13292","article-title":"A product of RpfB and RipA joint enzymatic action promotes the resuscitation of dormant mycobacteria","volume":"282","author":"Nikitushkin","year":"2015","journal-title":"Febs j"},{"key":"10.1016\/j.vaccine.2024.02.039_b0095","doi-asserted-by":"crossref","unstructured":"Hett EC, Rubin EJ. Bacterial growth and cell division: a mycobacterial perspective. Microbiol Mol Biol Rev. 2008;72:126-56, table of contents.","DOI":"10.1128\/MMBR.00028-07"},{"key":"10.1016\/j.vaccine.2024.02.039_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/cells8060609","article-title":"The cell wall hydrolytic NlpC\/P60 endopeptidases in mycobacterial cytokinesis: A structural perspective","volume":"8","author":"Squeglia","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.vaccine.2024.02.039_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.636644","article-title":"Mycobacterium tuberculosis RipA dampens TLR4-mediated host protective response using a multi-pronged approach involving autophagy, apoptosis, metabolic repurposing, and immune modulation","volume":"12","author":"Shariq","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0110","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1002\/eji.201445329","article-title":"Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells","volume":"45","author":"Choi","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0115","doi-asserted-by":"crossref","first-page":"15560","DOI":"10.1038\/s41598-019-52146-0","article-title":"Long-term protective efficacy with a BCG-prime ID93\/GLA-SE boost regimen against the hyper-virulent Mycobacterium tuberculosis strain K in a mouse model","volume":"9","author":"Kwon","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.02.039_b0120","doi-asserted-by":"crossref","first-page":"4246","DOI":"10.1038\/s41598-019-38982-0","article-title":"Mycobacterium tuberculosis Rv3463 induces mycobactericidal activity in macrophages by enhancing phagolysosomal fusion and exhibits therapeutic potential","volume":"9","author":"Park","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.02.039_b0125","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1096\/fj.201802604R","article-title":"Vaccine efficacy of a Mycobacterium tuberculosis Beijing-specific proline-glutamic acid (PE) antigen against highly virulent outbreak isolates","volume":"33","author":"Kwon","year":"2019","journal-title":"Faseb j"},{"key":"10.1016\/j.vaccine.2024.02.039_b0130","article-title":"Antigen-specific IFN-\u03b3\/IL-17-Co-producing CD4(+) T-cells are the determinants for protective efficacy of tuberculosis subunit vaccine","volume":"8","author":"Choi","year":"2020","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2024.02.039_b0135","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.228700","article-title":"PPE39 of the Mycobacterium tuberculosis strain Beijing\/K induces Th1-cell polarization through dendritic cell maturation","volume":"132","author":"Choi","year":"2019","journal-title":"J Cell Sci"},{"key":"10.1016\/j.vaccine.2024.02.039_b0140","doi-asserted-by":"crossref","first-page":"15824","DOI":"10.1038\/s41598-022-20017-w","article-title":"BCG\u0394BCG1419c increased memory CD8(+) T cell-associated immunogenicity and mitigated pulmonary inflammation compared with BCG in a model of chronic tuberculosis","volume":"12","author":"Kwon","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2024.02.039_b0145","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2011.02496.x","article-title":"Dendritic cell-targeted protein vaccines: a novel approach to induce T-cell immunity","volume":"271","author":"Trumpfheller","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.vaccine.2024.02.039_b0150","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1146\/annurev.immunol.021908.132703","article-title":"Cell-mediated immune responses in tuberculosis","volume":"27","author":"Cooper","year":"2009","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0155","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1128\/IAI.69.4.2666-2674.2001","article-title":"Gamma interferon-producing CD4+ T lymphocytes in the lung correlate with resistance to infection with Mycobacterium tuberculosis","volume":"69","author":"Chackerian","year":"2001","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2024.02.039_b0160","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nm1592","article-title":"Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major","volume":"13","author":"Darrah","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2024.02.039_b0165","doi-asserted-by":"crossref","first-page":"522","DOI":"10.4049\/jimmunol.179.1.522","article-title":"The hypervirulent Mycobacterium tuberculosis strain HN878 induces a potent TH1 response followed by rapid down-regulation","volume":"179","author":"Ordway","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.599386","article-title":"Screening for Mycobacterium tuberculosis infection using beijing\/K strain-specific peptides in a school outbreak cohort","volume":"11","author":"Hong","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0175","first-page":"824","article-title":"Transmission of Mycobacterium tuberculosis among high school students in Korea","volume":"5","author":"Kim","year":"2001","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.vaccine.2024.02.039_b0180","doi-asserted-by":"crossref","first-page":"e2018036","DOI":"10.4178\/epih.e2018036","article-title":"Tuberculosis control in the Republic of Korea","volume":"40","author":"Cho","year":"2018","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.vaccine.2024.02.039_b0185","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chom.2020.10.003","article-title":"Ultra-low dose aerosol infection of mice with Mycobacterium tuberculosis more closely models human tuberculosis","volume":"29","author":"Plumlee","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2024.02.039_b0190","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2958.2007.06078.x","article-title":"The resuscitation-promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro","volume":"67","author":"Kana","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41541-023-00623-z","article-title":"Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice","volume":"8","author":"Afkhami","year":"2023","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.02.039_b0200","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1574-6976.2012.00331.x","article-title":"Mycobacterium tuberculosis: success through dormancy","volume":"36","author":"Gengenbacher","year":"2012","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2024.02.039_b0205","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41577-019-0174-z","article-title":"Moving tuberculosis vaccines from theory to practice","volume":"19","author":"Andersen","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0210","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.ijtb.2019.04.012","article-title":"The roles of latency-associated antigens in tuberculosis vaccines","volume":"66","author":"Yousefi Avarvand","year":"2019","journal-title":"Indian J Tuberc"},{"key":"10.1016\/j.vaccine.2024.02.039_b0215","doi-asserted-by":"crossref","first-page":"e0130641","DOI":"10.1371\/journal.pone.0130641","article-title":"Multi-stage tuberculosis subunit vaccine candidate LT69 provides high protection against Mycobacterium tuberculosis infection in mice","volume":"10","author":"Niu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.02.039_b0220","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1128\/CVI.00271-15","article-title":"Synthetic long peptide derived from Mycobacterium tuberculosis latency antigen Rv1733c protects against tuberculosis","volume":"22","author":"Coppola","year":"2015","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0225","first-page":"11","article-title":"Peptidoglycan hydrolases RipA and Ami1 are critical for replication and persistence of Mycobacterium tuberculosis in the host","author":"Healy","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.vaccine.2024.02.039_b0230","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41541-018-0057-5","article-title":"The TLR-4 agonist adjuvant, GLA-SE, improves magnitude and quality of immune responses elicited by the ID93 tuberculosis vaccine: first-in-human trial","volume":"3","author":"Coler","year":"2018","journal-title":"npj Vaccines"},{"key":"10.1016\/j.vaccine.2024.02.039_b0235","doi-asserted-by":"crossref","first-page":"8047","DOI":"10.4049\/jimmunol.0801592","article-title":"Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells","volume":"182","author":"Lindenstr\u00f8m","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0240","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1016\/j.vaccine.2015.05.088","article-title":"Safety and immunogenicity of candidate vaccine M72\/AS01E in adolescents in a TB endemic setting","volume":"33","author":"Penn-Nicholson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.02.039_b0245","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1016\/j.vaccine.2015.06.051","article-title":"First-in-human trial of the post-exposure tuberculosis vaccine H56:IC31 in Mycobacterium tuberculosis infected and non-infected healthy adults","volume":"33","author":"Luabeya","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.02.039_b0250","doi-asserted-by":"crossref","first-page":"e0145234","DOI":"10.1371\/journal.pone.0145234","article-title":"Virulence-dependent alterations in the kinetics of immune cells during pulmonary infection by Mycobacterium tuberculosis","volume":"10","author":"Kim","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2024.02.039_b0255","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/s41564-018-0231-6","article-title":"Host resistance to pulmonary Mycobacterium tuberculosis infection requires CD153 expression","volume":"3","author":"Sallin","year":"2018","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0260","doi-asserted-by":"crossref","first-page":"1100741","DOI":"10.3389\/fimmu.2023.1100741","article-title":"Maintenance and recall of memory T cell populations against tuberculosis: Implications for vaccine design","volume":"14","author":"Liu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0265","doi-asserted-by":"crossref","first-page":"12434","DOI":"10.1073\/pnas.0703510104","article-title":"Poor correlation between BCG vaccination-induced T cell responses and protection against tuberculosis","volume":"104","author":"Mittr\u00fccker","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2024.02.039_b0270","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/eji.201040455","article-title":"Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection","volume":"40","author":"Caccamo","year":"2010","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2024.02.039_b0275","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1038\/s41598-021-86054-z","article-title":"Detection of differentially culturable tubercle bacteria in sputum using mycobacterial culture filtrates","volume":"11","author":"Gordhan","year":"2021","journal-title":"Sci Rep"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24001981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T17:41:39Z","timestamp":1731346899000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24001981"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0264410X24001981"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.039","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenicity and protective efficacy of RipA, a peptidoglycan hydrolase, against Mycobacterium tuberculosis Beijing outbreak strains","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.02.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}